Logo

Business, Policy & Funding

Breaking news on Genetics & Genomics business, policy & funding.

New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More

23andMe Counting on Lemonaid Health to Achieve Vision of Personalized Care
Premium

The telehealth and telepharmacy services provided through last year's Lemonaid Health acquisition will help 23andMe integrate genetics into patient care.

People in the News at OraSure, Element Biosciences, Micronoma, More

Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit

Guardant claimed that a patent lawsuit filed against it by Illumina in March was filed in an inappropriate district court and is a “brazen attempt” to stifle competition.

In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More

News items for the week of May 23, 2022.

May 27, 2022

Multiomics Startup Pleno Targeting Sequencing, PCR Markets With New Molecular Detection Technology
Premium

May 26, 2022

23andMe Fiscal Q4 Revenues Increase 14 Percent

May 26, 2022

Local Coverage Determinations Roundup: Castle Bio, SkylineDx

May 26, 2022

CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test 

May 26, 2022

Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test

May 26, 2022

QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel

May 25, 2022

StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test

May 25, 2022

Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays

May 25, 2022

Multiomics Startup Pleno Closes $15M Funding Round

May 25, 2022

SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit

May 25, 2022

Angle Gets FDA Clearance for Breast Cancer Cell Isolation System

May 25, 2022

Genes2Me Obtains CE Marking for Clinical Sequencing Panels

May 25, 2022

Genomic Testing Cooperative Gets CE-IVD Marks for Molecular Cancer Tests, Liquid Biopsy Profiles

May 25, 2022

Centogene Gets CE-IVD Mark for Cloud-Based Genetic Diagnostics Software Platform

May 24, 2022

Agilent Technologies Fiscal Q2 Revenues Rise 5 Percent

May 24, 2022

UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
Premium

May 24, 2022

Startup Incubator IndieBio, GP-Write Launch Initiative to Fund Genome Engineering Firms

May 24, 2022

Precipio Receives CE-IVD Mark for Hematologic Cancer Panels

May 24, 2022

Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection

May 24, 2022

BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel

Breaking News
The Scan

Blend of Omicron With Delta

The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant.

Limited Contrast

The New York Times reports that there is a shortage of a contrast agent used for some medical scans.

Pig Improvement

Farmers in China are using genetics to improve their hog herds, according to Reuters.

Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More

In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.